KH-01500

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameKH-01500

Drug Alias Nameapo-E4 agonist (Abbott)apolipoprotein-E4 agonist (Abbott)apolipoprotein-E4 agonist (Kos Pharmaceuticals)apolipoprotein-E4 mimetic peptide (Kos Pharmaceuticals)apolipoprotein-E4 mimetic peptide (Abbott) +[7]

ClassificationSmall molecules > Peptidomimetic

Mechanisms of ActionApolipoprotein E4 modulators

TargetsApolipoprotein E4

Therapy Area/IndicationsAtherosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesKos Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAbbott Laboratories Kos Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A